Indeed, Wnt5a and other constituents of the Wnt pathway have been suggested as promising therapeutic targets in ovarian cancer, as activation of this pathway has been linked to the progression of the disease [64,65]. The gene discussed is WNT5A; the disease is ovarian carcinoma.